Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the record history and the v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:52:06.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    New screenshot shows minor visual/layout adjustments to the Record History page; substantive study data and sections remain unchanged.
    Difference
    0.1%
    Check dated 2026-04-09T08:28:38.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new history version (v39, 2026-03-26) with a Study Status update was added; the 2025-08-06 entry was removed.
    Difference
    0.3%
    Check dated 2026-04-02T04:48:07.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0 as an addition and v3.4.3 as a deletion.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The history page adds revision v3.4.3 and removes revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:49:07.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the record history and removed the prior government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:55:37.000Z thumbnail image

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.